Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Share Option Grant

16 Mar 2021 11:42

RNS Number : 4383S
Creightons PLC
16 March 2021
Ā 

Creightons Plc

(the "Company" or "the Group")

Share Option Grant

This notification is made in accordance with DTR 3.1.4R(1)(a).

Creightons plc announces that options over a total of 1,965,000 ordinary 1p shares in the Company have been granted to 481 employees of companies in the Group as part of the Company's policy of providing long-term share-linked and tax-effective incentives to all employees of the Group employees and directors.

These options have been granted under the Company's 2018 Share Option Plan and represent a dilution of 3.03% of the Company's total equity.

The Board believes this is an effective way of rewarding service and commitment to the Group and to provide on-going incentives to all employees and directors.

The options were issued at 74.50p per ordinary share and can be exercised between the third and tenth anniversary of 16th March 2021, subject to the option holder's continued employment and the Company's share price having been not less than 74.50p per share for three consecutive days on or after 16th March 2024. No consideration is payable in respect of the grant of these options.

Shareholders will benefit from this grant since it re-enforces the Company's policy of providing long-term share-linked and tax-effective incentives to all our employees.

Ā 

Enquiries:

Ā 

Creightons plc

Ā 

NDJ O'Shea, Director

01733 281 000

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCDKABQDBKDDND
Date   Source Headline
23rd Apr 20263:05 pmRNSConfirmation of name change to Potter & Moore
23rd Apr 20267:01 amRNSChange of Name
23rd Apr 20267:00 amRNSTrading update for the year ended 31 March 2026
27th Mar 20264:35 pmRNSDirector / PDMR Shareholding
12th Mar 20265:42 pmRNSBlock Admission Six Monthly Return
5th Feb 202610:23 amRNSDirector/PDMR Shareholding
29th Jan 20269:31 amRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSInterim results for six months ended 30 Sept 2025
15th Sep 20257:00 amRNSBlock Listing and Total Voting Rights
29th Aug 20257:00 amRNSTotal Voting Rights
28th Aug 20253:22 pmRNSResults of Annual General Meeting
14th Aug 20257:00 amRNSExercise of Options, Director Dealing and TVR
30th Jul 20257:00 amRNSPosting of FY25 Annual Report and Notice of AGM
29th Jul 20251:28 pmRNSHoldings(s) in Company
23rd Jul 20252:11 pmRNSPDMR Dealing
16th Jul 20257:00 amRNSFY25 Audited Results and Notice of AGM
9th Jul 202510:30 amRNSNotice of Final Results and Investor Presentation
22nd May 20253:26 pmRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSPromotion of CFO to the Board of Directors
2nd Apr 20257:00 amRNSNotification of transactions by PDMR
1st Apr 20257:00 amRNSNotification of transactions by PDMR
31st Mar 20258:00 amRNSReadmission - Creightons Plc
31st Mar 20257:00 amRNSAdmission to AIM and first day of dealings
25th Mar 20253:23 pmRNSBoard Appointment
24th Mar 20256:00 pmRNSCreightons
20th Mar 202511:36 amRNSDirector/PDMR Shareholding
12th Mar 202512:43 pmRNSBlock listing Interim Review
3rd Mar 20257:33 amRNSResults of the General Meeting
28th Feb 20257:30 amRNSSchedule One - Creightons plc
6th Feb 20251:20 pmRNSProposed Delisting, Admission to AIM, Notice of GM
29th Jan 202512:59 pmRNSBoard Appointment
7th Jan 202511:46 amRNSHolding(s) in Company
10th Dec 20244:10 pmRNSDirectorate Change
28th Nov 20247:00 amRNSHalf-year Report
13th Nov 20247:00 amRNSUpdate on first half trading performance
28th Oct 20245:01 pmRNSNotification under UKLR 6.4.9(2)
25th Sep 20242:09 pmRNSDirector/PDMR Shareholding
20th Sep 202411:53 amRNSBlock listing Interim Review
18th Sep 20242:02 pmRNSTotal Voting Rights
4th Sep 20245:12 pmRNSDirector/PDMR Shareholding
29th Aug 20244:28 pmRNSResult of AGM
12th Aug 20242:14 pmRNSHolding(s) in Company
29th Jul 20243:45 pmRNSDividend Declaration
29th Jul 20241:52 pmRNSHolding(s) in Company
26th Jul 20242:59 pmRNSHolding(s) in Company
25th Jul 20245:30 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSPreliminary Results, Notice of AGM
8th Jul 20247:00 amRNSUpdate on Asset Impairment and Notice of Results
15th Mar 202410:52 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.